Harvard Apparatus Regenerative Technology (HRGN) Stock Statistics & Valuation Metrics

Harvard Apparatus Regenerative Technology has a market cap or net worth of $46.65M. The enterprise value is $18.57T.

Market Cap

$46.65M

Enterprise Value

$18.57T

Harvard Apparatus Regenerative Technology has 20,284,472 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding

20,284,472

Owned by Insiders

6.57%

Owned by Institutions

0.07%

Harvard Apparatus Regenerative Technology’s return on equity (ROE) is -6.50 and return on invested capital (ROIC) is -606.61%.

Return on Equity (ROE)

-6.50

Return on Assets (ROA)

-2.57

Return on Invested Capital (ROIC)

-606.61%

Return on Capital Employed (ROCE)

-6.67

Revenue Per Employee

88.00K

Profits Per Employee

-858.63K

Employee Count

8

Asset Turnover

0.26

Inventory Turnover

40.38

The current PE Ratio of Harvard Apparatus Regenerative Technology is -5.79. Harvard Apparatus Regenerative Technology’s PEG ratio is 3.94.

PE Ratio

-5.79

PS Ratio

47.07

PB Ratio

-29.32

Price to FCF

-11.12

Price to Operating Cash Flow

-11.12

PEG Ratio

3.94

In the last 12 months, Harvard Apparatus Regenerative Technology had revenue of 704.00K and earned -6.87M in profits. Earnings per share was -0.42.

Revenue

704.00K

Gross Profit

58.00K

Operating Income

-7.62M

Pretax Income

-6.87M

Net Income

-6.87M

EBITDA

-6.76M

Earnings Per Share (EPS)

-0.42

In the last 12 months, operating cash flow was -3.63M and capital expenditures 0, giving a free cash flow of -3.63M billion.

Operating Cash Flow

-3.63M

Free Cash Flow

-3.63M

Free Cash Flow per Share

-0.21

Harvard Apparatus Regenerative Technology pays an annual dividend of ―, resulting in a dividend yield of ―

Dividend Per Share

―

Dividend Yield

―

Payout Ratio

N/A

Free Cash Flow Yield

-8.99%

Earnings Yield

-16.53%

Beta

-0.11

52-Week Price Change

19.48%

50-Day Moving Average

2.06

200-Day Moving Average

1.61

Relative Strength Index (RSI)

59.77

Average Volume (3m)

2,341

Harvard Apparatus Regenerative Technology upcoming earnings date is ―, TBA (Confirmed).

Last Earnings Date

Aug 19, 2025

Next Earnings Date

―

Ex-Dividend Date

―

Harvard Apparatus Regenerative Technology as a current ratio of 1.19, with Debt / Equity ratio of 18.83%

Current Ratio

1.19

Quick Ratio

1.18

Debt to Market Cap

0.01

Net Debt to EBITDA

0.17

Interest Coverage Ratio

-952.38

In the past 12 months, Harvard Apparatus Regenerative Technology has paid 0 in taxes.

Income Tax

0

Effective Tax Rate

0.00

Harvard Apparatus Regenerative Technology EV to EBITDA ratio is -6.20, with an EV/FCF ratio of -11.20.

EV to Sales

47.42

EV to EBITDA

-6.20

EV to Free Cash Flow

-11.20

EV to Operating Cash Flow

-11.20

Harvard Apparatus Regenerative Technology has $351.00K in cash and marketable securities with $645.00K in debt, giving a net cash position of -$294.00K billion.

Cash & Marketable Securities

$351.00K

Total Debt

$645.00K

Net Cash

-$294.00K

Net Cash Per Share

-$0.01

Tangible Book Value Per Share

-$0.08

Gross margin is -5.70%, with operating margin of -821.77%, and net profit margin of -778.00%.

Gross Margin

-5.70%

Operating Margin

-821.77%

Pretax Margin

-778.00%

Net Profit Margin

-778.00%

EBITDA Margin

-764.49%

EBIT Margin

-777.07%

The average price target for Harvard Apparatus Regenerative Technology is ―, which is 11.43% higher than the current price. The consensus rating is ―

Price Target

―

Price Target Upside

―

Analyst Consensus

―

Analyst Count

―

Revenue Growth Forecast

44.62%

EPS Growth Forecast

9.81%

Smart Score

―

AI Score

52